Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
74.34
-3.86 (-4.94%)
At close: Jul 31, 2026, 4:00 PM EDT
74.75
+0.41 (0.55%)
After-hours: Jul 31, 2026, 7:34 PM EDT

KNSA Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Equivalents
175.68189.95165.6174.86192.04157.13183.5897.3899.27141.08107.95117.83112.5780.62122.72175.7694.3163.32122.47190.18
Short-Term Investments
350.25278.14248.48177.24115.75111.2160.05126.4119.4972.4798.4283.2672.43106.8867.8924.9643.982.2559.7310
Cash & Short-Term Investments
525.93468.09414.07352.1307.78268.34243.63223.78218.76213.55206.37201.08184.99187.49190.61200.72138.21145.58182.2200.18
Cash Growth (YoY)
70.88%74.44%69.96%57.34%40.70%25.66%18.05%11.29%18.25%13.90%8.27%0.18%33.85%28.79%4.61%0.27%-38.81%-44.86%-43.68%-45.06%
Accounts Receivable
23.4923.2215.5951.7431.9140.0741.7224.8920.451621.273.0424.657.4212.6611.167.8129.443.993.22
Other Receivables
--------------7.66-----
Total Trade Receivables
23.4923.2215.5951.7431.9140.0741.7224.8920.451621.273.0424.657.4220.3211.167.8129.443.993.22
Inventory
70.9373.1454.941.448.1822.0726.3628.6834.8627.2831.1225.5823.9623.4321.614.6219.9213.223.685.61
Other Current Assets
48.2929.7142.6130.2932.4425.4320.0833.9526.9513.7717.5426.412.4413.1610.5415.3114.0110.526.598.5
Total Current Assets
668.63594.17527.18475.53420.31355.91331.8311.3301.02270.59276.3256.11246.04231.5243.06241.82179.94198.76196.45217.51
Net Property, Plant & Equipment
10.9311.3211.7511.7311.3811.0611.0411.6612.413.0412.6713.5914.336.627.048.176.227.298.389.3
Other Intangible Assets
14.751515.2515.515.751616.2516.516.751717.2517.517.751818.2518.518.751919.2519.5
Other Long-Term Assets
201.8204.79209.46209.58213.71216.36221.47215.84212.25219.05220.11195.87206.22186.74191.32191.475.675.928.726.55
Total Assets
896.11825.28763.63712.33661.15599.33580.55555.3542.43519.67526.32483.06484.33442.86459.67459.95210.58230.97232.8252.86
Accounts Payable
12.424.42.036.158.961.982.048.337.395.638.251.010.651.397.91.472.523.381.871.65
Accrued Expenses
134.78108.35112.0494.2288.3575.980.5169.5363.3244.7244.6741.1535.3220.8930.1130.8734.538.8938.0328.53
Current Portion of Leases
4.013.172.992.72.522.291.992.032.092.282.252.312.243.483.33.273.343.313.383.25
Unearned Revenue
--------0.010.160.312.564.676.5-12.09----
Other Current Liabilities
20.0520.6922.1320.521817.0916.0816.0711.4811.438.196.434.64.335.758.793.194.771.541
Total Current Liabilities
171.25156.61139.18123.59117.8397.27100.6295.9684.2964.2163.6753.4747.4736.5947.0756.4943.5450.3544.8234.43
Long-Term Leases
4.895.866.517.027.247.627.868.569.329.8610.0110.6511.282.132.623.441.282.12.673.5
Other Long-Term Liabilities
65.8357.1350.3346.3441.0736.9533.6313.7713.7313.713.8113.8213.9214.0513.8416.0212.2612.270.270.89
Total Long-Term Liabilities
70.7162.9856.8453.3648.3244.5741.522.3423.0423.5723.8224.4725.216.1816.4619.4513.5414.372.944.38
Total Liabilities
241.96219.59196.03176.95166.14141.84142.12118.29107.3387.7887.4877.9472.6852.7763.5275.9557.0864.7247.7638.81
Common Stock
0.020.020.020.020.020.020.020.020.020.0200.020.020.020.020.020.020.020.020.02
Additional Paid-in Capital
1,0701,0461,0301,012989.81970.24959.72949.28934.77927.58916.76908.3900.96894.33888.12880.55874.15866.94860.48853.14
Accumulated Other Comprehensive Income
-1.38-0.67-0.03-0.16-0.05-0.17-0.16-0.04-0.13-0.050.01-00.010.060.04-0.07-0.09-0.1-0.07-0.05
Retained Earnings
-414.11-439.55-462.14-476.34-494.77-512.6-521.14-512.26-499.56-495.65-477.95-503.19-489.33-504.3-492.03-496.5-720.59-700.61-675.4-639.06
Shareholders' Equity
654.15605.69567.61535.38495.01457.49438.44437.01435.1431.9438.84405.13411.66390.1396.15384.01153.49166.24185.04214.05
Total Liabilities & Equity
896.11825.28763.63712.33661.15599.33580.55555.3542.43519.67526.32483.06484.33442.86459.67459.95210.58230.97232.8252.86
Total Debt
8.99.039.59.729.779.929.8610.611.412.1412.2612.9613.525.625.926.714.615.416.056.75
Net Cash (Debt)
517.03459.07404.58342.38298.02258.43233.77213.19207.36201.41194.11188.12171.47181.88184.69194.02133.59140.17176.15193.44
Net Cash Growth (YoY)
73.49%77.64%73.06%60.60%43.72%28.31%20.43%13.32%20.93%10.74%5.10%-3.04%28.35%29.76%4.85%0.30%-39.20%-45.55%-44.34%-46.69%
Net Cash Per Share
6.205.574.964.283.823.393.232.972.922.852.672.682.392.612.592.751.932.032.552.82
Book Value
654.15605.69567.61535.38495.01457.49438.44437.01435.1431.9438.84405.13411.66390.1396.15384.01153.49166.24185.04214.05
Book Value Per Share
7.847.356.966.696.356.016.066.096.136.116.045.775.755.595.555.442.222.402.683.12
Tangible Book Value
639.4590.69552.36519.88479.26441.49422.19420.51418.35414.9421.59387.63393.91372.1377.9365.51134.74147.24165.79194.55
Tangible Book Value Per Share
7.677.176.776.506.155.805.845.865.895.875.805.525.505.335.295.181.942.132.402.83
SEC Filings: 10-K · 10-Q